Workflow
乐普医疗: 关于持股5%以上股东2024年面向专业投资者非公开发行科技创新可交换公司债券(第一期)换股价格调整的公告

Core Viewpoint - The announcement details the adjustment of the conversion price for the "24 Ship Material EB" bonds issued by China Shipbuilding Industry Corporation 725 Research Institute, affecting the shares of Lepu Medical Technology (Beijing) Co., Ltd. Group 1: Conversion Price Adjustment - The conversion price before adjustment was 21.53 CNY per share, and after adjustment, it is 21.39 CNY per share, effective from June 20, 2025 [1][2]. - The adjustment is due to the distribution of cash dividends, with a cash dividend of 0.135 CNY per share (tax included) to be distributed to shareholders as of June 19, 2025 [1][2]. Group 2: Bond Details - The total balance of the "24 Ship Material EB" bonds is 200 million CNY, with 18.4 million shares of the company pledged as collateral for the repayment of these bonds [2][3]. - The bonds are intended for exchange with the shares held by the 725 Research Institute, and the number of shares available for exchange will not be less than the total shares required for the conversion of the outstanding bonds [2]. Group 3: Compliance and Commitments - As of the announcement date, the 725 Research Institute has no commitments related to the reduction of its holdings in the company's stock [3]. - The shares intended for exchange do not have any restrictions or rights defects that would affect investors' conversion rights [3].